|
Volumn 502, Issue 7470, 2013, Pages
|
Waiting for results
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
DETECTION METHOD;
DISEASE CONTROL;
DISEASE PREVALENCE;
DISEASE TREATMENT;
ELECTRICITY SUPPLY;
EPIDEMIC;
HUMAN IMMUNODEFICIENCY VIRUS;
MORTALITY;
RESOURCE SCARCITY;
RURAL AREA;
TECHNOLOGICAL DEVELOPMENT;
TUBERCULOSIS;
AFRICA;
ARTICLE;
EASTERN EUROPE;
HEALTH CENTER;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
LIGHT EMITTING DIODE;
MOLECULAR DIAGNOSTICS;
MULTIDRUG RESISTANT TUBERCULOSIS;
MYCOBACTERIUM TUBERCULOSIS;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PULMONOLOGIST;
SOUTH AFRICA;
SPUTUM;
TUBERCULOSIS;
ZAMBIA;
AFRICA SOUTH OF THE SAHARA;
ANTIBIOTIC RESISTANCE;
ECONOMICS;
GENETICS;
MICROBIOLOGY;
MOLECULAR DIAGNOSIS;
POLYMERASE CHAIN REACTION;
STANDARD;
COMPLICATION;
HIV INFECTIONS;
STANDARDS;
SUB-SAHARAN AFRICA;
ZAMBIA;
AFRICA SOUTH OF THE SAHARA;
ANTITUBERCULAR AGENTS;
DRUG RESISTANCE, BACTERIAL;
HIV INFECTIONS;
HUMANS;
MOLECULAR DIAGNOSTIC TECHNIQUES;
MYCOBACTERIUM TUBERCULOSIS;
POLYMERASE CHAIN REACTION;
TUBERCULOSIS;
|
EID: 84885574019
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/502S10a Document Type: Article |
Times cited : (6)
|
References (3)
|